We’re announcing the integration of advanced batch normalization into our core pipeline. This is a significant step forward in simplifying cytometry for global clinical trials.
Current normalization tools require users to fine-tune default parameters. Translational scientists are (rightly) worried that if they set the wrong parameters, the batch normalization won’t run as planned. And as a result, cytometry users have either skipped batch normalization or struggled mightily to get things working. That era is over. With our integrated solution, our scientists do the heavy lifting of fine-tuning parameters, to make sure your results reflect biological reality.
The enhanced batch normalization delivers:
Building on this, we are set to introduce intuitive dashboard features that will make batch normalization clear and accessible for drug developers. Translational scientists’ other major concern is about the “black box” nature of batch normalization.
Our planned features will make batch normalization easily accessible and interpretable (without getting a PhD in math):
Visualization of batch correction metrics: on app.teiko.bio, we will display batch correction metrics, such as inter-batch CV, in real time, allowing users to see exactly how data is standardized. Built-in guides and visual cues will explain each step of the normalization process, eliminating the need for specialized expertise and addressing hesitancy about algorithm outputs.